These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 19442087)

  • 21. Defeating Leishmania resistance to miltefosine (hexadecylphosphocholine) by peptide-mediated drug smuggling: a proof of mechanism for trypanosomatid chemotherapy.
    Luque-Ortega JR; de la Torre BG; Hornillos V; Bart JM; Rueda C; Navarro M; Amat-Guerri F; Acuña AU; Andreu D; Rivas L
    J Control Release; 2012 Aug; 161(3):835-42. PubMed ID: 22609351
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intestinal absorption of miltefosine: contribution of passive paracellular transport.
    Ménez C; Buyse M; Dugave C; Farinotti R; Barratt G
    Pharm Res; 2007 Mar; 24(3):546-54. PubMed ID: 17252190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interaction between miltefosine and amphotericin B: consequences for their activities towards intestinal epithelial cells and Leishmania donovani promastigotes in vitro.
    Ménez C; Buyse M; Besnard M; Farinotti R; Loiseau PM; Barratt G
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3793-800. PubMed ID: 16966395
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tat peptide and hexadecylphosphocholine introduction into pegylated liposomal doxorubicin: An in vitro and in vivo study on drug cellular delivery, release, biodistribution and antitumor activity.
    Teymouri M; Badiee A; Golmohammadzadeh S; Sadri K; Akhtari J; Mellat M; Nikpoor AR; Jaafari MR
    Int J Pharm; 2016 Sep; 511(1):236-244. PubMed ID: 27363937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetic behavior and antineoplastic activity of liposomal hexadecylphosphocholine.
    Kaufmann-Kolle P; Drevs J; Berger MR; Kötting J; Marschner N; Unger C; Eibl H
    Cancer Chemother Pharmacol; 1994; 34(5):393-8. PubMed ID: 8070005
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A mitochondrial HSP70 (HSPA9B) is linked to miltefosine resistance and stress response in Leishmania donovani.
    Vacchina P; Norris-Mullins B; Carlson ES; Morales MA
    Parasit Vectors; 2016 Dec; 9(1):621. PubMed ID: 27906059
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of ceramide-mediated apoptosis by the anticancer phospholipid analog, hexadecylphosphocholine.
    Wieder T; Orfanos CE; Geilen CC
    J Biol Chem; 1998 May; 273(18):11025-31. PubMed ID: 9556584
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hexadecylphosphocholine inhibits phosphatidylcholine biosynthesis and the proliferation of HepG2 cells.
    Jiménez-López JM; Carrasco MP; Segovia JL; Marco C
    Eur J Biochem; 2002 Sep; 269(18):4649-55. PubMed ID: 12230578
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The antitumor phospholipid analog, hexadecylphosphocholine, activates cellular phospholipase D.
    Wieder T; Zhang Z; Geilen CC; Orfanos CE; Giuliano AE; Cabot MC
    Cancer Lett; 1996 Feb; 100(1-2):71-9. PubMed ID: 8620456
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hexadecylphosphocholine (Miltefosine) stabilized chitosan modified Ampholipospheres as prototype co-delivery vehicle for enhanced killing of L. donovani.
    Tripathi P; Jaiswal AK; Dube A; Mishra PR
    Int J Biol Macromol; 2017 Dec; 105(Pt 1):625-637. PubMed ID: 28716750
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of hexadecylphosphocholine on fatty acid metabolism: relation to cytotoxicity.
    Goppelt-Struebe M; Winter I
    Cancer Chemother Pharmacol; 1995; 35(6):519-26. PubMed ID: 7882461
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of hexadecylphosphocholine on membrane phospholipid metabolism in human tumour cells.
    Berkovic D; Grunwald U; Menzel W; Unger C; Hiddemann W; Fleer EA
    Eur J Cancer; 1995 Nov; 31A(12):2080-5. PubMed ID: 8562169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential regulation of phospholipase A2 in human leukemia cells by the etherphospholipid analogue hexadecylphosphocholine.
    Berkovic D; Lüders S; Goeckenjan M; Hiddemann W; Fleer EA
    Biochem Pharmacol; 1997 Jun; 53(11):1725-33. PubMed ID: 9264326
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interactions of antileishmanial drugs with monolayers of lipids used in the development of amphotericin B-miltefosine-loaded nanocochleates.
    Pham TT; Barratt G; Michel JP; Loiseau PM; Saint-Pierre-Chazalet M
    Colloids Surf B Biointerfaces; 2013 Jun; 106():224-33. PubMed ID: 23434716
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of hexadecylphosphocholine on phosphatidylcholine and phosphatidylserine metabolism in human lymphoma cells.
    Berkovic D; Sievers S; Haase D; Fleer EA; Binder C
    J Exp Ther Oncol; 2002; 2(2):85-92. PubMed ID: 12415624
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Investigations on the cellular uptake of hexadecylphosphocholine.
    Fleer EA; Berkovic D; Eibl H; Unger C
    Lipids; 1993 Aug; 28(8):731-6. PubMed ID: 8377589
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cellular uptake and retention measurements of alkylphosphocholines in the SK-BR-3 breast cancer and Molt-4 leukemia cell line using capillary gas chromatography.
    Brochez V; Van Heuverswyn D; Diniz JA; De Potter CR; Van den Eeckhout EG
    Lipids; 1999 May; 34(5):511-6. PubMed ID: 10380124
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanisms of experimental resistance of Leishmania to miltefosine: Implications for clinical use.
    Pérez-Victoria FJ; Sánchez-Cañete MP; Seifert K; Croft SL; Sundar S; Castanys S; Gamarro F
    Drug Resist Updat; 2006; 9(1-2):26-39. PubMed ID: 16814199
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hexadecylphosphocholine does not influence phospholipase D and sphingomyelinase activity in human leukemia cells.
    Berkovic D; Berkovic K; Binder C; Haase D; Fleer EA
    J Exp Ther Oncol; 2002; 2(4):213-8. PubMed ID: 12416025
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Edelfosine and miltefosine effects on lipid raft properties: membrane biophysics in cell death by antitumor lipids.
    Castro BM; Fedorov A; Hornillos V; Delgado J; Acuña AU; Mollinedo F; Prieto M
    J Phys Chem B; 2013 Jul; 117(26):7929-40. PubMed ID: 23738749
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.